Studies have shown differences in specific cognitive ability domains and risk of Alzheimer's
disease between the men and women at later age. However it is important to know that sex …

There is ample empirical evidence to support the notion that the biological impacts of
estrogen extend beyond the gonads to other bodily systems, including the brain and …

Vascular contributions to cognitive impairment and dementia (VCID) is the second most
common cause of dementia. While males overall appear to be at a slightly higher risk for …

Stroke remains a leading cause of mortality and disability worldwide. More women than men
have strokes each year, in part because women live longer. Women have poorer functional …

Silent mating type information regulation 2 homolog 1 (Sirt1), a nicotine adenine
dinucleotide (NAD+)-dependent enzyme, is well-known in playing a part in longevity …

Aims Stroke is a major cause of mortality and disability, especially for postmenopausal
women. In view of the protective action of estrogen, hormone therapy remains the only …

The neuroprotection research in the last 2 decades has witnessed a growing interest in the
functions of estrogens as neuroprotectants against neurodegenerative diseases including …

For post-menopausal women, stroke is complicated by the variable effects of estrogen
therapy and the age-related therapeutic consequences involved. Estrogen therapy has been …

Oestrogens trigger several pathways at the plasma membrane that exert beneficial actions
against neurodegenerative diseases, such as A lzheimer's disease and Parkinson's …

Ischemic stroke involves multiple pathophysiological mechanisms with complex interactions.
Efforts to decipher those mechanisms and understand the evolution of cerebral injury is key …